Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580398 · ClinicalTrials.gov registry record · Phase 1
Smoking Cessation Intervention for Thoracic Patients
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 49
- Enrollment target
NCT00580398: Completed Phase 1 study, sponsored by Massachusetts General Hospital.
NCT00580398 is a Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00580398, a Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 49 participants
- Enrollment target
Study Summary
The primary aim of the proposed study is to develop and assess the feasibility of delivering a smoking cessation intervention to patients undergoing lung surgery that begins before surgery and continues up to 3 months post-discharge. The secondary aim is to assess smoking cessation rates 3 months following surgery.
Interventions
- BEHAVIORAL Smoking cessation counseling
- DRUG varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2008-01 |
| Est. Completion | 2012-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00580398
The ClinicalTrials.gov registry entry for NCT00580398 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Smoking cessation counseling is the first listed.
NCT00580398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00580398 about?
NCT00580398 is a clinical study titled "Smoking Cessation Intervention for Thoracic Patients". The primary aim of the proposed study is to develop and assess the feasibility of delivering a smoking cessation intervention to patients undergoing lung surgery that begins before surgery and continues up to 3 months post-discharge. The secondary aim is to assess smoking cessation rates 3 months fo...
What is the current status of trial NCT00580398?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 49 participants. The study started on 2008-01. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00580398?
The interventions under investigation include: Smoking cessation counseling (BEHAVIORAL), varenicline (DRUG).
Who is sponsoring clinical trial NCT00580398?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.